<DOC>
	<DOC>NCT00669565</DOC>
	<brief_summary>This is a phase II, multicenter, single-arm, open-label safety and efficacy study of bavituximab in combination with carboplatin plus paclitaxel in patients with locally advanced or metastatic breast cancer.</brief_summary>
	<brief_title>Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Living in India for the duration of the study Adult females over age 18 years of age with a life expectancy of at least 3 months Confirmed breast cancer with evidence of locally advanced or metastatic disease Disease that is measurable by radiology imaging Ambulatory and capable of all selfcare but unable to carry out any work activities. Adequate laboratory results (hematologic, renal, hepatic) Negative pregnancy test History of or susceptibility to bleeding or coagulopathy (e.g., von Willebrand Disease or Hemophilia) Any history of thromboembolic events (clots within blood vessels) Ongoing treatment with high doses of anticoagulants Use of hormone therapy Advanced peripheral neuropathy (e.g., numbness, tingling, and/or pain in distal extremities) Prior chemotherapy, immunotherapy or radiotherapy to an area of measurable disease unless disease had recurred after radiotherapy Radiotherapy within 2 weeks entering the study Chemotherapy, immunotherapy or radiotherapy within 4 weeks of starting the study Allergies to Polysorbate 80 or drugs containing polyoxyethylated castor oil (e.g. cyclosporine) Diagnosed and active CNS disease or metastatic lesions Major surgery within 4 weeks of starting the study Pregnant or nursing Uncontrolled disease (e.g., diabetes, hypertension, thyroid disease) History of heart disease History of any condition requiring treatment with antiinflammatory, antiplatelet drugs or steroids Diagnosed with HIV or hepatitis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Locally Advanced or Metastatic Breast Cancer</keyword>
</DOC>